Lithium response in bipolar disorder: Genetics, genomics, and beyond

Area of Science:

• Psychiatry
• Genetics
• Pharmacogenomics

Background:

• Lithium is a key mood stabilizer for bipolar disorder (BD).
• Treatment response to lithium exhibits substantial inter-individual variability.
• Only 20-30% of BD patients are considered excellent responders, suggesting underlying biological differences.

Purpose of the Study:

• To explore the genetic underpinnings of lithium treatment response variability in bipolar disorder.
• To highlight the limitations of candidate gene studies and the potential of genome-wide association studies (GWAS).
• To identify future research directions for elucidating the complex biology of lithium response.

Main Methods:

• Review of existing literature on lithium response in BD.
• Analysis of findings from candidate gene studies.
• Emphasis on the insights gained from genome-wide association studies (GWAS).
• Discussion of emerging technologies like induced pluripotent stem cells and multi-omics data integration.

Main Results:

• Candidate gene studies have not identified major genes influencing lithium response.
• Lithium response is characterized as a polygenic trait, influenced by multiple genes.
• Larger GWAS with diverse ancestries are crucial for uncovering the genetic architecture.

Conclusions:

• Understanding lithium response requires moving beyond single-gene approaches.
• Future research should leverage advanced technologies and large-scale genetic studies.
• Integrating multi-omics data with machine learning may unlock insights into lithium's complex biological mechanisms.